OTC •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/16/2026 15:59
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOTC
Market Capitalization3,231.34 mln
Float306 mln
Earnings Date10/27/2026
EPS
0.52
Decent
P / E
8.70
Undervalued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.54
Likely reliable
Relative Strength
85
/ 100
Strongly outperforming
Debt / Equity
0.52
Moderate leverage
Business Description
Hypera S.A. is a Brazilian pharmaceutical company founded in 1999 and based in São Paulo, offering a wide range of consumer health products across many categories. These include pain relief, cold and flu treatments, digestive aids, skin care, vitamins, herbal remedies, antiseptics, and generic medicines, sold under dozens of well-known local brands. Originally called Hypermarcas S.A., the company adopted its current name in 2018.
